Clinical trials: Anomia (Word-Finding Impairment)
Anomia (Word-Finding Impairment), Aphasia
Anomia Treatment Predictors
The goal of this clinical trial is to identify predictors of response to phonological-focused anomia treatment in people with aphasia. The main question it aims to answer is who responds to which type of anomia treatment.
- Trial name
- NCT06619756
- Testing
- Phonomotor Treatment (PMT), Phonological Components Analysis (PCA)
- Where
- United States
- Volunteers
- 2 people
- Sponsor
- State University of New York at Buffalo
Aphasia, Anomia (Word-Finding Impairment)
Chronic Aphasia - Improved by Intensive Training and Electrical Brain Stimulation (CATS)
The purpose of this study is to determine if non-invasive electrical brain stimulation can enhance the outcome of intensive language therapy in chronic aphasia.
- Trial name
- NCT01924702
- Testing
- Intensive language therapy, transcranial direct current stimulation
- Where
- Germany
- Volunteers
- 24 people
- Sponsor
- Charité Neurocure AG Flöel
Aphasia
Criterion-learning Naming Treatment For Addressing Comprehension Deficits in Aphasia
Aphasia is a disorder of spoken and written language, most commonly following a stroke. It is estimated that between 2.5 and 4 million Americans are living with aphasia today.
- Trial name
- NCT07179458
- Testing
- Criterion-learning practice
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Albert Einstein Healthcare Network
Aphasia
Effects of Semantic Context on Criterion-learning Naming Treatment in Aphasia
Aphasia is a disorder of spoken and written language, most commonly following a stroke. It is estimated that between 2.5 and 4 million Americans are living with aphasia today.
- Trial name
- NCT07673198
- Testing
- Criterion-learning practice
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Albert Einstein Healthcare Network
Aphasia
Criterion-learning Based Naming Treatment in Aphasia
Aphasia is a disorder of spoken and written language, most commonly following a stroke. It is estimated that between 2.5 and 4 million Americans are living with aphasia today.
- Trial name
- NCT06364709
- Testing
- Criterion-learning practice
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- Albert Einstein Healthcare Network
Mild Cognitive Impairment, Dementia, Mild
Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment
The goal of this clinical trial is to compare a precision medicine approach to the standard-of-care for people with mild cognitive impairment or early-stage dementia.
- Trial name
- EVANTHEA (NCT05894954)
- Testing
- Precision Medicine Approach, Hormones and Medications tailored to lab tests, combined with devices that support stress management and brain exercises, Standard-of-Care
- Where
- 6 sites in United States
- Volunteers
- 73 people
- Sponsor
- Alzheimer's Prevention and Reversal Project, Inc.